Related Experiment Video
Updated: Jul 12, 2025

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Published on: January 24, 2016
ARF6-dependent endocytic trafficking of the Interferon-γ receptor drives adaptive immune resistance in cancer
Yinshen Wee1,2,3,4, Junhua Wang1,2,3, Emily C Wilson1,2
1Department of Pathology, University of Utah, Salt Lake City, Utah.
Abstract:
Adaptive immune resistance (AIR) is a protective process used by cancer to escape elimination by CD8+ T cells. Inhibition of immune checkpoints PD-1 and CTLA-4 specifically target Interferon-gamma (IFNγ)-driven AIR. AIR begins at the plasma membrane where tumor cell-intrinsic cytokine signaling is initiated. Thus, plasma membrane remodeling by endomembrane trafficking could regulate AIR. Herein we report that the trafficking protein ADP-Ribosylation Factor 6 (ARF6) is critical for IFNγ-driven AIR. ARF6 prevents transport of the receptor to the lysosome, augmenting IFNγR expression, tumor intrinsic IFNγ signaling and downstream expression of immunosuppressive genes. In murine melanoma, loss of ARF6 causes resistance to immune checkpoint blockade (ICB). Likewise, low expression of ARF6 in patient tumors correlates with inferior outcomes with ICB. Our data provide new mechanistic insights into tumor immune escape, defined by ARF6-dependent AIR, and support that ARF6-dependent endomembrane trafficking of the IFNγ receptor influences outcomes of ICB.
Insights
Cancer uses adaptive immune resistance (AIR) to evade T cells. This study reveals ADP-Ribosylation Factor 6 (ARF6) is key to this process, impacting cancer
Area of Science:
- Immunology
- Cancer Biology
- Cell Biology
Background:
- Adaptive immune resistance (AIR) allows tumors to evade CD8+ T cell elimination.
- Immune checkpoint inhibitors targeting PD-1 and CTLA-4 focus on Interferon-gamma (IFNγ)-driven AIR.
- Tumor cell-intrinsic cytokine signaling, initiated at the plasma membrane, suggests endomembrane trafficking regulates AIR.
Approach:
- Investigated the role of the trafficking protein ADP-Ribosylation Factor 6 (ARF6) in IFNγ-driven AIR.
- Examined ARF6's effect on Interferon-gamma Receptor (IFNγR) trafficking and signaling.
- Assessed the impact of ARF6 loss on immune checkpoint blockade (ICB) resistance in murine melanoma models and patient tumors.
Key Points:
- ARF6 is critical for IFNγ-driven AIR by preventing IFNγR lysosomal transport, thus increasing cell-surface IFNγR expression.
- This augmentation enhances tumor-intrinsic IFNγ signaling and promotes immunosuppressive gene expression.
- Loss of ARF6 confers resistance to ICB in a murine melanoma model.
Conclusions:
- ARF6-dependent endomembrane trafficking of the IFNγ receptor is a novel mechanism of tumor immune escape.
- Low ARF6 expression in patient tumors correlates with poor outcomes following ICB treatment.
- Targeting ARF6-mediated trafficking presents a potential strategy to overcome adaptive immune resistance and improve ICB efficacy.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Recycling Endosomes and Transcytosis
The recycling endosome is not a single organelle but an extensively tubulated network of recycling pathways. It functions in storing molecules or transporting them across...
Intracellular Signaling Affects Focal Adhesions
Some...
Receptor-mediated Endocytosis

